In the last fiscal quarter of 2013 Myriad Genetics' business faced some challenges, although one wouldn't know it by looking at the company's earnings.

In May, actress Angelina Jolie wrote in a New York Times editorial about her decision to get a preventive double mastectomy after learning she harbored BRCA mutations. In the same piece, she mentioned that the cost of BRCA testing is more than $3,000 in the US and "remains an obstacle for many women."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.